http://www.surfaceoncology.com
Surface Oncology, Inc. Company Intro
Surface Oncology is developing next generation immunotherapies that target the immune-suppressive tumor microenvironment to attack cancer.
Industry
Healthcare
Surface Oncology, Inc. Headquaters
50 Hampshire Street
Cambridge,02139
United States
Surface Oncology, Inc. Share price
22 Jan 2021 02:39 GMT
$14.02
0.2 (1.45 %)
Surface Oncology, Inc. Market cap
$545.476 M
WMC RANKING
2021
Surface Oncology, Inc. # 108
BiotechnologyLatest Surface Oncology, Inc. News
09 Jan 2021
BidaskClub Upgrades Surface Oncology (NASDAQ:SURF) to ...
Institutional investors and hedge funds own 55.59% of the company's stock. About Surface Oncology. Surface Oncology, Inc, a clinical-stage immuno-oncology ...
09 Jan 2021
BidaskClub Upgrades Surface Oncology (NASDAQ:SURF) to ...
Institutional investors and hedge funds own 55.59% of the company's stock. About Surface Oncology. Surface Oncology, Inc, a clinical-stage immuno-oncology ...
09 Jan 2021
BidaskClub Upgrades Surface Oncology (NASDAQ:SURF) to ...
Institutional investors and hedge funds own 55.59% of the company's stock. About Surface Oncology. Surface Oncology, Inc, a clinical-stage immuno-oncology ...
WMC Market Score
WMC Market to Revenue Score
Surface Oncology, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Surface Oncology, Inc. | USD | $39,031 | $61,747 | $-23,965 | $5,455M | 108 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $571,390B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $349,360B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $620,550B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $271,640B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Surface Oncology, Inc. Social Followers vs Top 4 Industry Competitors
Surface Oncology, Inc. Post vs Top 4 Industry Competitors
Surface Oncology, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Surface Oncology, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Surface Oncology, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Surface Oncology, Inc. | 0.42 | 0.30 | 0 | 0 | 0 | 0 | 0.16 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.33 | 29.44 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.28 | 100 | 60 | 0 | 0 | 90.10 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.77 | 86 | 0 | 0 | 99.40 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
